Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-5995

MIPS 462 Bone Density

XMLWordPrintable

    • Icon: EC eCQMs - Eligible Clinicians EC eCQMs - Eligible Clinicians
    • Resolution: Answered
    • Icon: Moderate Moderate
    • None
    • None
    • Hide
      ​Thank you for your question on CMS645 Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy. The measure uses RXNorm codes found in the Androgen deprivation therapy for Urology Care (2.16.840.1.113762.1.4.1151.48) valueset to define ADT. The codes to valueset can be found on the NIH Value Set Authority Center website: https://vsac.nlm.nih.gov/. The measure logic then uses the ADT medication order or medication active start dates to meet the measure criteria.
      Show
      ​Thank you for your question on CMS645 Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy. The measure uses RXNorm codes found in the Androgen deprivation therapy for Urology Care (2.16.840.1.113762.1.4.1151.48) valueset to define ADT. The codes to valueset can be found on the NIH Value Set Authority Center website: https://vsac.nlm.nih.gov/ . The measure logic then uses the ADT medication order or medication active start dates to meet the measure criteria.
    • CMS0645v6
    • High

      Hi,

      I am reaching out to you to gather more information surrounding how we should define ADT (Androgen Deprivation Therapy). The specification does not specifically state how this should be defined. Should we use codes, drug names?

            edave Mathematica EC eCQM Team
            adhoward4 Andrea Howard (Inactive)
            Votes:
            0 Vote for this issue
            Watchers:
            3 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: